Another meta-analysis showed that HPV positive HNSCC patients display significant improved outcomes with PD-1/PD-L1 axis blockage treatment compared to HPV negative HNSCC patients (46). This evidence concerns the gene CD274 and head and neck squamous cell carcinoma.